2025年12月期第2四半期の業績予想と実績値の差異に関するお知らせ

This document informs about the discrepancies between the earnings forecast and actual results for the second quarter of the fiscal year ending December 2025. The actual results exceeded the forecasts published on February 13, 2025, with sales up by 24.2%, operating profit by 67.2%, ordinary profit by 60.7%, and net income by 66.4%. This positive outcome is attributed to the strong sales of medical information systems, including electronic medical records, driven by the promotion of medical DX. There are no changes to the full-year earnings forecast, and any significant updates will be disclosed promptly.